Development of reagents and assays for the detection of pathogenic Burkholderia species.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3593192)

Published in Faraday Discuss on January 01, 2011

Authors

Omar Qazi1, Mridula Rani, Annie J Gnanam, Thomas W Cullen, Christopher M Stead, Haley Kensing, Kate McCaul, Sarah Ngugi, Joann L Prior, Alexandria Lipka, Judit M Nagy, C Whitlock Gregory, Barbara M Judy, Sarah V Harding, Richard W Titball, Sachdev S Sidhu, M Stephen Trent, G Barrie Kitto, Alfredo Torres, D Mark Estes, Brent Iverson, George Georgiou, Katherine A Brown

Author Affiliations

1: Institute for Cellular and Molecular Biology, The University of Texas at Austin, 1 University Station A4800, Austin, Texas 78712, USA.

Articles cited by this

Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71

Melioidosis. Lancet (2003) 11.74

Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A (2004) 7.30

Glanders in a military research microbiologist. N Engl J Med (2001) 4.77

Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci U S A (2004) 4.13

Suppression of non-specific binding in serological Luminex assays. J Immunol Methods (2005) 2.96

High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol (2007) 2.88

PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect Dis (2004) 2.56

Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiol (2006) 2.35

Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP system. J Microbiol Methods (2003) 2.26

High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol (2004) 2.14

A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10

Melioidosis. Curr Opin Infect Dis (2006) 1.98

Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett (2007) 1.90

Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Mol Microbiol (2005) 1.83

Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg (2006) 1.82

Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol (2004) 1.82

Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J Bacteriol (2005) 1.71

Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates. Clin Diagn Lab Immunol (1998) 1.68

Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. J Vet Med B Infect Dis Vet Public Health (2005) 1.56

Point-of-care testing for pandemic influenza and biothreats. Disaster Med Public Health Prep (2009) 1.53

Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol Microbiol (2006) 1.31

Molecular and physical characterization of Burkholderia mallei O antigens. J Bacteriol (2002) 1.26

Prevalence-dependent use of serological tests for diagnosing glanders in horses. BMC Vet Res (2009) 1.20

Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J Clin Microbiol (2008) 1.18

THE INDIRECT HAEMAGGLUTINATION TEST IN THE DIAGNOSIS OF MELIOIDOSIS IN GOATS. Br Vet J (1965) 1.15

The eradication of glanders in Canada. Can Vet J (2002) 1.14

Development and evaluation of polymerase chain reaction assay to detect Burkholderia genus and to differentiate the species in clinical specimens. FEMS Microbiol Lett (2010) 1.07

High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei. Infect Immun (2007) 1.07

Development of a polymerase chain reaction assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae. Diagn Microbiol Infect Dis (2006) 1.04

groEL encodes a highly antigenic protein in Burkholderia pseudomallei. Clin Diagn Lab Immunol (2001) 1.03

The identification of surface proteins of Burkholderia pseudomallei. Vaccine (2006) 1.02

Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Clin Vaccine Immunol (2009) 1.01

Comparative proteomic profiles and the potential markers between Burkholderia pseudomallei and Burkholderia thailandensis. Mol Cell Probes (2006) 0.98

Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice. Diagn Microbiol Infect Dis (2007) 0.95

Sero-characterization of lipopolysaccharide from Burkholderia thailandensis. Trans R Soc Trop Med Hyg (2008) 0.86

In silico analysis of potential diagnostic targets from Burkholderia pseudomallei. Trans R Soc Trop Med Hyg (2008) 0.82

Development of aptamers specific for potential diagnostic targets in Burkholderia pseudomallei. Trans R Soc Trop Med Hyg (2008) 0.79

Articles by these authors

Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60

Tularemia. Clin Microbiol Rev (2002) 8.51

Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A (2004) 7.30

The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet (2005) 6.22

Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol (2004) 5.38

Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell (2008) 5.37

Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect (2003) 4.19

Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat Biotechnol (2007) 3.56

A specificity map for the PDZ domain family. PLoS Biol (2008) 3.16

Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science (2004) 3.08

Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis. J Clin Microbiol (2003) 3.08

High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol (2007) 2.88

Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res (2006) 2.84

High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol (2013) 2.81

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat Biotechnol (2002) 2.77

Absence of Yersinia pestis-specific DNA in human teeth from five European excavations of putative plague victims. Microbiology (2004) 2.75

Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. Genome Res (2003) 2.51

Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol (2010) 2.41

Crystal structure of full-length KcsA in its closed conformation. Proc Natl Acad Sci U S A (2009) 2.35

Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology (2004) 2.28

Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway. Proc Natl Acad Sci U S A (2003) 2.26

Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res (2006) 2.24

A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni. Proc Natl Acad Sci U S A (2010) 2.21

The many faces of glutathione in bacteria. Antioxid Redox Signal (2006) 2.20

Regulation of a late phase of T cell polarity and effector functions by Crtam. Cell (2008) 2.18

Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A (2004) 2.17

ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect Immun (2004) 2.15

Mre11-Rad50-Xrs2 and Sae2 promote 5' strand resection of DNA double-strand breaks. Nat Struct Mol Biol (2010) 2.14

High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol (2004) 2.14

The bacterial twin-arginine translocation pathway. Annu Rev Microbiol (2006) 2.13

A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10

Periplasmic phosphorylation of lipid A is linked to the synthesis of undecaprenyl phosphate. Mol Microbiol (2007) 2.05

Bacterial biosynthesis of cadmium sulfide nanocrystals. Chem Biol (2004) 2.02

The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun (2011) 2.00

Viral assembly of oriented quantum dot nanowires. Proc Natl Acad Sci U S A (2003) 2.00

Conformational control of the Ste5 scaffold protein insulates against MAP kinase misactivation. Science (2012) 1.92

Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ Health Perspect (2003) 1.91

Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem (2014) 1.90

Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett (2007) 1.90

Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol (2013) 1.88

Molecular recognition by a binary code. J Mol Biol (2005) 1.85

Rapid evolution of functional complexity in a domain family. Sci Signal (2009) 1.85

Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics (2007) 1.85

Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc Natl Acad Sci U S A (2012) 1.83

Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol (2004) 1.82

The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother (2011) 1.78

Bayesian modeling of the yeast SH3 domain interactome predicts spatiotemporal dynamics of endocytosis proteins. PLoS Biol (2009) 1.78

Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. MBio (2011) 1.76

Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum. Biochem J (2007) 1.75

Genetic analysis of the twin arginine translocator secretion pathway in bacteria. J Biol Chem (2002) 1.74

Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol Microbiol (2009) 1.71

From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics (2007) 1.68

The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J Cell Biol (2007) 1.66

Inhibition of Wnt signaling by Dishevelled PDZ peptides. Nat Chem Biol (2009) 1.65

The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins. ACS Chem Biol (2009) 1.65

A genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence. PLoS Pathog (2010) 1.65

Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis. Mol Microbiol (2006) 1.65

Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol Biochem Parasitol (2003) 1.61

A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect Immun (2002) 1.60

The Erbin PDZ domain binds with high affinity and specificity to the carboxyl termini of delta-catenin and ARVCF. J Biol Chem (2002) 1.59

Comprehensive and quantitative mapping of energy landscapes for protein-protein interactions by rapid combinatorial scanning. J Biol Chem (2006) 1.59

Clostridium taeniosporum spore ribbon-like appendage structure, composition and genes. Mol Microbiol (2007) 1.58

Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis (2005) 1.56

Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol (2004) 1.55

Addition of missing loops and domains to protein models by x-ray solution scattering. Biophys J (2002) 1.54

Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Natl Acad Sci U S A (2004) 1.54

Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A. J Biol Chem (2004) 1.52

Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol (2006) 1.51

Synthetic antibodies for specific recognition and crystallization of structured RNA. Proc Natl Acad Sci U S A (2007) 1.51

Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol (2006) 1.50

Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A (2014) 1.50

Convergent and divergent ligand specificity among PDZ domains of the LAP and zonula occludens (ZO) families. J Biol Chem (2006) 1.49

Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology (2006) 1.49

Origins of PDZ domain ligand specificity. Structure determination and mutagenesis of the Erbin PDZ domain. J Biol Chem (2002) 1.49

Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries. Nat Protoc (2007) 1.49

Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis. J Med Microbiol (2003) 1.48

Estrogen increases menopausal host susceptibility to experimental ascending urinary-tract infection. J Infect Dis (2007) 1.48

Engineering of protease variants exhibiting high catalytic activity and exquisite substrate selectivity. Proc Natl Acad Sci U S A (2005) 1.48

Why high-error-rate random mutagenesis libraries are enriched in functional and improved proteins. J Mol Biol (2005) 1.47

Effects of codon usage versus putative 5'-mRNA structure on the expression of Fusarium solani cutinase in the Escherichia coli cytoplasm. Protein Expr Purif (2003) 1.46

Modulating the innate immune response by combinatorial engineering of endotoxin. Proc Natl Acad Sci U S A (2013) 1.45

Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology. Chem Biol (2013) 1.45

A dominant conformational role for amino acid diversity in minimalist protein-protein interfaces. J Mol Biol (2008) 1.45

Functional, structural, and spectroscopic characterization of a glutathione-ligated [2Fe-2S] cluster in poplar glutaredoxin C1. Proc Natl Acad Sci U S A (2007) 1.45

Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis. J Immunol Methods (2003) 1.44

A strategy for modulation of enzymes in the ubiquitin system. Science (2013) 1.43

Comparative structural analysis of the Erbin PDZ domain and the first PDZ domain of ZO-1. Insights into determinants of PDZ domain specificity. J Biol Chem (2006) 1.43

The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J Bacteriol (2006) 1.43

The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun (2006) 1.42

The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol (2008) 1.41

Two-state selection of conformation-specific antibodies. Proc Natl Acad Sci U S A (2009) 1.40

Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure. Liver Transpl (2008) 1.40